• Otilonium Bromide and NSP15: Evidence Boundaries

  2026-10-13

  The supplied SARS-CoV-2 study reports a computational screen that prioritized thymopentin and oleuropein against NSP15. It does not evaluate Otilonium Bromide, demonstrate biochemical inhibition, or establish antiviral or clinical effects. Otilonium Bromide remains supported here only as a supplier-described antimuscarinic research compound.

• What the NSP15 Screening Study Actually Shows

  2026-10-12

  A 2021 computational study identified thymopentin and oleuropein as promising predicted binders of SARS-CoV-2 NSP15. Its results support a hypothesis for future validation, not evidence of antiviral efficacy, clinical benefit, or activity by Otilonium Bromide.

• AZ505 and SMYD2 in Cisplatin-Related Renal Fibrosis

  2026-10-12

  Chen et al. report that pharmacological SMYD2 inhibition with AZ505 or LLY507 was associated with less cisplatin-related renal injury, fibrosis, and inflammatory signaling in a preclinical model and in cultured tubular epithelial cells. The findings support SMYD2 as a hypothesis-generating target in renal fibrosis, but do not establish clinical benefit, target exclusivity, or applicability to cancer indications.

• Nitrocefin in β-Lactamase Research: Evidence and Limits

  2026-10-11

  Nitrocefin is a chromogenic cephalosporin substrate used as a visual or spectrophotometric reporter of β-lactamase enzymatic activity. This overview examines its research context, conceptual applications in β-lactam antibiotic resistance research and β-lactamase inhibitor screening, and the limits of interpreting colorimetric results. It also places the 2024 MDockPeP2_VS study of peptide inhibitors targeting TEM-1 β-lactamase in context while distinguishing reported findings from broader interpretation.

• Five Questions About CIRT, DHODH and Ferroptosis

  2026-10-10

  A source-grounded overview of a 2025 preclinical study linking carbon-ion radiotherapy with DHODH suppression, ferroptosis and M1-like macrophage polarization in gastric cancer, including evidence quality, interpretation and translational limits.

• Angiotensin III: From RAAS Biology to Translation

  2026-10-09

  Angiotensin III is more than a downstream RAAS fragment. Its receptor biology, aldosterone activity, pressor effects, and emerging connection to SARS-CoV-2 spike–receptor binding position it as a valuable translational research probe—provided binding-assay findings are not overstated as clinical or infectious-disease evidence.

• Flubendazole and the Next Era of Autophagy Translation

  2026-10-09

  Flubendazole can be positioned as a research-use chemical probe for autophagy modulation, but translational value depends on separating pathway engagement from growth inhibition and cell death. This evidence-led perspective connects vendor-reported product characteristics with a broader framework for cancer biology research, assay interpretation, and future disease-model validation.

• GGFG Peptide: A Translational Linker Strategy

  2026-10-08

  Gly-Gly-Phe-Gly (GGFG) offers a defined peptide-linker framework for drug conjugation research, antibody-drug conjugate development, and biomaterial construction. This article connects its potential role in bioconjugation chemistry with the calcineurin-focused multiple myeloma findings reported by Imai and colleagues, while clearly separating established evidence from future hypotheses.

• Calpain, BDNF/TrkB, and Offspring Cognition

  2026-10-08

  A 2025 Neuropharmacology study links maternal non-obstetric surgery during pregnancy with excessive calpain activity, impaired hippocampal BDNF/TrkB signaling, and cognitive deficits in rat offspring. Pharmacological calpain inhibition or TrkB activation partially improved molecular, structural, and behavioral outcomes, supporting a mechanistic hypothesis while remaining limited to preclinical evidence.

• Bobcat339: TET Inhibition in Epigenetics

  2026-10-07

  Bobcat339 is a cytosine structure-based TET enzyme inhibitor reported to inhibit TET1 and TET2 in biochemical assays. Its value is strongest as a mechanistic epigenetics research compound, while its relevance to senile osteoporosis remains a hypothesis because the cited osteoporosis study did not report Bobcat339 as an intervention.

• SOD Activity Assay: Evidence, Uses, and Limits

  2026-10-07

  A source-grounded overview of Superoxide Dismutase Activity Assay Kit measurements, including the underlying colorimetric principle, research applications, evidence strength, comparison with hydrogen peroxide assays, and important interpretation limits.

• Primary Antibody Dilution Buffer in PCNSL Research

  2026-10-06

  Explore how Primary Antibody Dilution Buffer can support interpretable spatial follow-up of PCNSL single-cell discoveries. This article separates product attributes from biological evidence and examines how SLC2A5, fructose metabolism, hypoxia, and tumor–immune interactions should be interpreted across assay modalities.

• Pazopanib Hydrochloride: Research Evidence

  2026-10-06

  A source-grounded overview of Pazopanib Hydrochloride and GW786034, emphasizing its reported multi-kinase profile, the distinction between growth inhibition and cell death, conceptual applications in cancer research, and important evidence limitations.

• Trypsin as a Context-Controlled Research Reagent

  2026-10-05

  Trypsin is a serine protease whose value depends on biological context, not simply catalytic specificity. This article connects the research use of BA5744 with the R-loop and FTSJ3 findings in lung cancer while defining evidence boundaries for cell, membrane, and inflammation studies.

• Estradiol, ER Signaling, and CD4+ T-Cell Recovery

  2026-10-05

  Wang and colleagues identified endoplasmic reticulum stress as a mechanistic link between hemorrhagic shock and impaired splenic CD4+ T-lymphocyte function. Their receptor-selective experiments suggest that estradiol restores immune-cell activity mainly through ERα- and GPR30-associated signaling, rather than ERβ, providing a framework for studying post-traumatic immune dysfunction.

7994 records 1/533 page Next 12345 下5页 Last page